Daily pill slashes 'bad' cholesterol levels by 60% in year-long trial
A new daily pill called Enlicitide, developed by Merck, has been shown to reduce bad cholesterol levels by over 60% in a global study of adults with a genetic condition that elevates LDL cholesterol and raises the risk of early heart disease.